News
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...
Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Let's look at why this news could be a game-changer for Eli Lilly and its stock.
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...
Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results